Cabotegravir
ATC J05AJ04 · 10 markets · 39 records
AU 10 records · 5 strengths
- 30 mgtabletVocabriaVOCABRIA cabotegravir (as sodium) 30 mg film-coated tablet, bottle
- 600 mg/3 mLinjection · extended-releaseCabenuva
- 600 mginjectionAPRETUDE cabotegravir 600 mg/3 mL prolonged-release suspension for injection vialCABENUVA cabotegravir 600 mg/3 mL plus rilpivirine 900 mg/3 mL prolonged-release suspensions for injection vials
- 400 mginjectionCABENUVA cabotegravir 600 mg/3 mL plus rilpivirine 900 mg/3 mL prolonged-release suspensions for injection vials
Records without a stated strength · 1 Apretude、Cabenuva、Vocabria
CA 5 records · 2 strengths
GB 4 records · 2 strengths
- 30 mgtabletApretudeVocabria
- 600 mg/3 mLinjection · extended-releaseApretude 600mg/3ml prolonged-release suspension for injection vialsVocabria 600mg/3ml prolonged-release suspension for injection vials
ES 4 records · 2 strengths
MX 4 records · 2 strengths
Records without a stated strength · 2 Apretude、Vocabria Apretude、Vocabria
TW 4 records · 2 strengths
- 30 mgtabletApretudeVocabria、艾菩盾膜衣錠 30 毫克、莫帕滋膜衣錠30毫克
Records without a stated strength · 1 Apretude prolonged-release suspension for injection、Vocabria prolonged-release suspension for injection、艾菩盾長效注射劑、莫帕滋長效注射劑
HK 3 records · 1 strengths
Records without a stated strength · 1 Vocabria、Vocabria prolonged-release suspension for injection
SG 2 records · 1 strengths
- 200 mg/mLinjectionVocabria prolonged-release suspension for
EU 2 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Apretude、Vocabria
US 1 records · 1 strengths
- 30 mgtabletVocabria
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.